StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30517% above fair value
$61.36−0.63 (-1.02%)

Close on Nov 19, 2026Market cap $1.75BP/E 157.3Yield –

Eton Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Eton Pharmaceuticals's market cap was $1.94B on Nov 11, 2026, against $433.10M a year earlier. Over the last 5 years it ranged from $53.07M to $1.94B, with a median of $115.03M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.94B+326.7%
2025Dec 31, 2025$453.48M+31.8%
2024Dec 31, 2024$344.14M+206.2%
2023Dec 29, 2023$112.38M+57.5%
2022Dec 30, 2022$71.34M-32.4%
2021Dec 31, 2021$105.56M-38.1%
2020Dec 31, 2020$170.64M+33.1%
2019Dec 31, 2019$128.21M+236.9%
2018Dec 31, 2018$38.06M–

More Eton Pharmaceuticals figures

See a number that looks wrong?